A

AnMed Health IMA | Ambulatory Research

Research site

(Unclaimed)

Location

2000 E Greenville St Suite 3850, Anderson, South Carolina, United States of America

Site insights

Top conditions

Top treatments

Sugar

Cagrilintide

Metformin

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 2 total trials

A Research Study Comparing RYBELSUS® to Other Blood Sugar Lowering Tablets in People Living in America With Type 2 Diabetes (REALYSE)

This study is comparing the medicine RYBELSUS® to other medicines in people with type 2 diabetes who need extra treatment. All medicines used in this...

Active, not recruiting

Diabetes Mellitus, Type 2

Drug: oral glucose-lowering medications (commercially available)

Drug: semaglutide

A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor (REIMAGINE 2)

The study will look at how well CagriSema helps people lower their blood sugar and body weight. CagriSema is a new weekly medicine that combines two...

Enrolling

Type 2 Diabetes Mellitus

Drug: Cagrilintide

Drug: Semaglutide

Trial sponsors

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms